ストックスクリーナーアプリを入手
177.14
2.32%
4.01
アフターアワーズ：
177.14
前日終値:
$173.13
開ける：
$173.23
24時間の取引高:
187.70K
Relative Volume:
0.79
時価総額：
$3.47B
収益：
$152.42M
当期純損益:
$45.24M
株価収益率:
70.57
EPS:
2.51
ネットキャッシュフロー:
$6.97M
1週間 パフォーマンス:
+3.80%
1か月 パフォーマンス:
+9.54%
6か月 パフォーマンス:
+68.48%
1年 パフォーマンス:
+76.98%
1日の値動き範囲:
$172.36
$177.81
1週間の範囲:
$163.45
$177.81
52週間の値動き範囲:
$93.58
$177.81
Ligand Pharmaceuticals Inc Stock (LGND) Company Profile
名前
Ligand Pharmaceuticals Inc
セクター
電話
858-550-7500
住所
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA
LGND を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LGND
Ligand Pharmaceuticals Inc
|
177.14 | 3.38B | 152.42M | 45.24M | 6.97M | 2.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Ligand Pharmaceuticals Inc Stock (LGND) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-10 | 開始されました | Stifel | Buy |
| 2024-10-03 | 開始されました | Oppenheimer | Outperform |
| 2024-07-30 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-04-14 | 再開されました | Stephens | Overweight |
| 2021-02-04 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-06 | 開始されました | Barclays | Overweight |
| 2020-03-24 | ダウングレード | Argus | Buy → Hold |
| 2020-03-10 | 開始されました | Guggenheim | Neutral |
| 2020-02-06 | 開始されました | The Benchmark Company | Buy |
| 2019-09-19 | アップグレード | Barclays | Equal Weight → Overweight |
| 2019-06-11 | 開始されました | Barclays | Equal Weight |
| 2019-05-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-03-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-10-29 | アップグレード | ROTH Capital | Neutral → Buy |
| 2018-10-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-09-11 | 繰り返されました | Argus | Buy |
| 2018-08-17 | 開始されました | Goldman | Neutral |
| 2018-08-08 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2018-06-21 | 開始されました | Argus | Buy |
| 2017-12-27 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-09-05 | 再開されました | H.C. Wainwright | Buy |
| 2016-10-05 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-08-05 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2016-03-11 | 開始されました | Sidoti | Buy |
| 2016-03-03 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Ligand Pharmaceuticals Inc (LGND) 最新ニュース
Ligand Pharmaceuticals IncorporatedEquity Right (LGNYZ) Price Target Increased by 410.53% to 0.05 - Nasdaq
Ligand Pharmaceuticals stock hits 52-week high at $172.49 By Investing.com - Investing.com Canada
Can Ligand Pharmaceuticals Incorporated stock deliver sustainable ROE2025 Short Interest & Long-Term Safe Investment Plans - newser.com
What drives Ligand Pharmaceuticals Incorporated LGDN stock priceBollinger Bands Signals & Affordable Stock Market Tips - earlytimes.in
What drives Ligand Pharmaceuticals Incorporated stock priceHead and Shoulders Patterns & Small Budget Capital Gains - Early Times
What analysts say about Ligand Pharmaceuticals Incorporated LGDN stockDividend Reinvestment Plans & Small Investment Growth Tips - Early Times
Ligand Pharmaceuticals Hits New 52-Week High of $170.78 - Markets Mojo
Ligand Pharmaceuticals Hits New 52-Week High of $172.45 - Markets Mojo
Congress Asset Management Co. Raises Stake in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals director Aryeh sells $1.7 million in shares By Investing.com - Investing.com Australia
LGND: Ligand Pharmaceuticals Inks $11M Royalty Deal with Arecor - GuruFocus
Arecor Therapeutics announces royalty financing agreement with Ligand to raise up to $11 mln - MarketScreener
Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292 - GlobeNewswire Inc.
Ligand Pharmaceuticals director Aryeh sells $1.7 million in shares - Investing.com
Ligand Pharmaceuticals (NASDAQ:LGND) Hits New 12-Month HighTime to Buy? - MarketBeat
Contravisory Investment Management Inc. Acquires New Holdings in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Analysts Set Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) PT at $176.50 - MarketBeat
Strs Ohio Takes Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
What earnings revisions data tells us about Ligand Pharmaceuticals IncorporatedJuly 2025 Big Picture & Smart Swing Trading Alerts - newser.com
Jobs Data: What is the dividend yield of Ligand Pharmaceuticals IncorporatedQuarterly Portfolio Report & Smart Allocation Stock Tips - khodrobank.com
Is now a turning point for Ligand Pharmaceuticals IncorporatedTrade Analysis Summary & Weekly Market Pulse Updates - newser.com
Will Ligand Pharmaceuticals Incorporated rebound enough to break even2025 AllTime Highs & Daily Chart Pattern Signals - newser.com
Aug Setups: Is Ligand Pharmaceuticals Incorporated in a long term uptrendMarket Performance Summary & Capital Efficient Trading Techniques - خودرو بانک
Rate Cut: Can Ligand Pharmaceuticals Incorporated outperform in the next rallyWatch List & Advanced Swing Trade Entry Alerts - خودرو بانک
Earnings visualization tools for Ligand Pharmaceuticals Incorporated2025 Market Outlook & Long-Term Safe Return Strategies - newser.com
Ligand Pharmaceuticals stock hits 52-week high at $169.72 By Investing.com - Investing.com Canada
Rhumbline Advisers Sells 1,989 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Analyzing Ligand Pharmaceuticals (NASDAQ:LGND) and Provectus Biopharmaceuticals (OTCMKTS:PVCT) - Defense World
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Average Rating of “Buy” by Analysts - Defense World
Volume Recap: Is Ligand Pharmaceuticals Incorporated being accumulated by smart money2025 Trading Volume Trends & Advanced Swing Trade Entry Plans - خودرو بانک
Aug Final Week: Will Ligand Pharmaceuticals Incorporated benefit from rising consumer demandPortfolio Risk Report & Weekly Setup with High ROI Potential - خودرو بانک
Using data filters to optimize entry into Ligand Pharmaceuticals IncorporatedForecast Cut & Free Growth Oriented Trading Recommendations - newser.com
Aug Rallies: Will Ligand Pharmaceuticals Incorporated outperform the market in YEARJuly 2025 Momentum & Stepwise Entry and Exit Trade Signals - خودرو بانک
Aug Fed Impact: Will Ligand Pharmaceuticals Incorporated benefit from rising consumer demandJuly 2025 Rallies & Stock Portfolio Risk Management - خودرو بانک
Ellsworth Advisors LLC Acquires Shares of 7,272 Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals entered third amendment to credit agreementSEC filing - MarketScreener
Ligand Pharmaceuticals Entered Third Amendment To Credit AgreementSEC Filing - TradingView
Earnings Risk: Is Ligand Pharmaceuticals Incorporated a stock for growth or value investorsMarket Performance Summary & Daily Oversold Stock Bounce Ideas - خودرو بانک
Pullback Watch: Will Ligand Pharmaceuticals Incorporated benefit from rising consumer demandQuarterly Earnings Summary & AI Driven Price Predictions - خودرو بانک
Growth Value: What is Ligand Pharmaceuticals Incorporated’s TAM (Total Addressable Market)Entry Point & Consistent Income Trade Recommendations - خودرو بانک
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Sees Significant Increase in Short Interest - MarketBeat
Market Moves: What is the next catalyst for Ligand Pharmaceuticals IncorporatedJuly 2025 Breakouts & Daily Profit Focused Stock Screening - خودرو بانک
What’s the recovery path for long term holders of Ligand Pharmaceuticals IncorporatedJuly 2025 Market Mood & Precise Buy Zone Tips - newser.com
Real time social sentiment graph for Ligand Pharmaceuticals IncorporatedJuly 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - newser.com
Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Baird Financial Group Inc. - MarketBeat
Visual analytics tools that track Ligand Pharmaceuticals Incorporated performanceTrade Exit Summary & Verified Short-Term Plans - newser.com
Jacobs Levy Equity Management Inc. Makes New $16.53 Million Investment in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals Inc (LGND) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):